The association between the expression of GPX3 and the prognosis in AML patients conducted by Cox regression analysis showed that lower GPX3 expression group was significantly associated with lower complete remission (CR) (P = 0.048) and higher mortality rates (P = 0.001). Here, GPX3 is linked to acute myeloid leukemia.